Mini Quiz: Educating patients about DME

Poll

How can ophthalmologists better educate patients about the severity of DME progression?

A). Employ the use of OCT images to educate patients when describing their condition.
B). Emphasize that chronic means forever
C). Recognize the importance of the five-year delay between glycemic control and microvascular healing
D). Urge patients to undergo combination therapy
E). Monitor treatment approaches
F). All the above

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!
Recent Videos
Related Content
Central choroidal thickness: Important biomarker for assessing response to aflibercept in treatment-naive DME

Central choroidal thickness: Important biomarker for assessing response to aflibercept in treatment-naive DME

Lynda Charters
April 28th 2025
Article
FDA issues CRL for Regeneron's aflibercept 8 mg (Eylea HD) sBLA

FDA issues CRL for Regeneron's aflibercept 8 mg (Eylea HD) sBLA

Martin David Harp;Hattie Hayes;Kassi Filkins
April 21st 2025
Article
Geographic and institutional disparities identified in DR and DME clinical trials

Geographic and institutional disparities identified in DR and DME clinical trials

Sydney M Crago
April 19th 2025
Article
Racial disparities in visual outcomes of ranibizumab-treated DME

Racial disparities in visual outcomes of ranibizumab-treated DME

Lynda Charters
April 18th 2025
Article
Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema

Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema

Martin David Harp
March 24th 2025
Article
Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200

Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200

Martin David Harp
March 21st 2025
Article
© 2025 MJH Life Sciences

All rights reserved.